NCT05242315 - Extended-Release Tacrolimus Following Liver Transplantation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 15, 2022

Primary Completion Date

December 15, 2026

Study Completion Date

February 15, 2034

Conditions

Liver Transplant; ComplicationsRenal InsufficiencyImmunosuppressant Adverse ReactionMetabolic SyndromeCardiovascular Diseases

Interventions

DRUG

Envarsus Oral Product

as described in arm/group description

DRUG

Prograf (SOC)

Trial Locations (1)

RECRUITING

Univerity of Alberta, Edmonton

All Listed Sponsors

lead

University of Alberta

OTHER